Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CLOVER HEALTH ($CLOV) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of $0.02 per share, beating estimates of -$0.07 by ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Clover Health Investments (CLOV – Research Report). The company’s shares closed yesterday at $4.32.

Clover Health Investments Corp (NASDAQ:CLOV) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $382.55 million, and the earnings are expected to ...